Alerts will be sent to your verified email
Verify Email
BALAXI
|
Balaxi Pharma.
|
Alpa Lab
|
Kimia Biosciences
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
28.02 % | 10.02 % | 24.83 % |
|
5yr average Equity Multiplier
|
1.4 | 1.26 | 66.02 |
|
5yr Average Asset Turnover Ratio
|
1.43 | 0.62 | 1.14 |
|
5yr Avg Net Profit Margin
|
11.03 % | 13.26 % | -0.67 % |
|
Price to Book
|
0.51 | 0.71 | 11.48 |
|
P/E
|
12.79 | 11.17 | 13.86 |
|
5yr Avg Cash Conversion Cycle
|
154.28 Days | 114.37 Days | -33.97 Days |
|
Inventory Days
|
87.41 Days | 51.33 Days | 101.63 Days |
|
Days Receivable
|
103.86 Days | 142.78 Days | 98.68 Days |
|
Days Payable
|
63.18 Days | 94.49 Days | 171.28 Days |
|
5yr Average Interest Coverage Ratio
|
57.05 | 94.43 | 0.78 |
|
5yr Avg ROCE
|
36.52 % | 13.16 % | 10.6 % |
|
5yr Avg Operating Profit Margin
|
16.64 % | 7.55 % | 3.89 % |
|
5 yr average Debt to Equity
|
0.09 | 0.02 | 29.85 |
|
5yr CAGR Net Profit
|
-5.76 % | 21.88 % | 13.51 % |
|
5yr Average Return on Assets
|
18.47 % | 7.94 % | -0.69 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
65.99 % | 57.29 % | 74.94 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
-6.7 % | 0.0 | 0.0 |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Balaxi Pharma.
|
Alpa Lab
|
Kimia Biosciences
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
-
|
Product Wise Break-Up
|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
-
|
Product Wise Break-Up
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
-
|
Location Wise Break-Up
|
|
Drug Delivery Break-Up
|
Drug Delivery Break-Up
|
-
|
-
|
|
Therapeutic Area Break-Up
|
Therapeutic Area Break-Up
|
-
|
-
|